ARCHIVES

FDA Designates Zometa For Priority Review.

This article is from The Cancer Letter archive.

Vol. 27 No. 44 | November 30, 2001

Download PDF Visit The Full Archive

Related Articles

Hope for FDA authority over tobacco products dies in Congress.

October 15, 2004

National Cancer Policy Board will end in 2005, NCI to support a cancer forum at IOM.

November 5, 2004

Senate Increases NIH Funding for 2013, Rejects President’s $200+ Million Increase for Program Evaluation Activities

June 22, 2012

NTP Staff Members In Bethesda Told They Must Move

December 16, 1983

Frozen Section Analysis Helps Avoid Second Surgery

September 30, 2005

Genentech Reps Not Welcome: Hospitals Urge Drug Maker to Reverse Policy On Supplying Avastin, Rituxan, & Herceptin

October 17, 2014